To investigate the clinical relevance of CD4+cMet+ T cells observed in animal models, we examined the expression of c-Met receptor and Itgα4 by CD4+ T cells in human PBMCs of matched-age untreated patients with MS and patients with other neurological disease (OND). This evidence concerns the gene ITGA4 and myeloid sarcoma.